Long

VitaDAO

Matrix

Andy

Binance Labs, the venture arm of the cryptocurrency exchange Binance, has announced its first investment in decentralized science, or “DeSci,” by partnering with BIO Protocol.
<h2 id="span-style-font-weight-400-what-is-the-bio-protocol-span">What is the BIO Protocol?</h2>
<a href="https://www.bio.xyz/" rel="noopener noreferrer nofollow">BIO Protocol</a> is an accelerator dedicated to reshaping the way health sciences are funded and commercialized. It does so by supporting a network of biotech-focused Decentralized Autonomous Organizations, or BioDAOs, that address funding gaps in underrepresented areas, such as rare disease research, longevity studies, and emerging health issues. This collaboration marks a <a href="https://thecoinrise.com/binance-labs-backs-bitcoin-liquid-staking-startup-lombard-finance/" rel="noopener noreferrer nofollow">notable diversification for Binance Labs</a>, which has primarily focused on decentralized finance projects until now.
BIO Protocol, through its network of BioDAOs, offers a platform where communities can co-own and fund research projects, providing crucial support for new therapies and drug development. “BIO Protocol represents a significant step forward in DeSci by merging biotechnology and DeFi,” commented Binance Labs Investment Director Andy Chang, emphasizing the potential for impactful, real-world technological advancements through this new investment.
<h2 id="span-style-font-weight-400-expanding-biodao-projects-and-innovations-span">Expanding BioDAO Projects and Innovations</h2>
Binance Labs has not disclosed the amount invested in BIO Protocol, but the funds will support the expansion of new projects within the BioDAO ecosystem. By providing seed funding and other resources, Binance Labs aims to strengthen BIO Protocol’s community and tokenomics structure. Among the initiatives BIO Protocol has introduced are <a href="https://thecoinrise.com/top-art-museum-in-france-to-display-nfts/" rel="noopener noreferrer nofollow">Intellectual Property NFTs</a> (IP-NFTs), a concept pioneered by BIO Protocol’s co-founder Paul Kohlhaas, which enables the secure sale and exchange of intellectual property.
The BIO Protocol network consists of eight BioDAOs, with a collective market cap of $200 million as of late 2023. Among these is VitaDAO, a longevity-focused BioDAO founded in 2021, which received a significant $4.1 million investment from Pfizer in early 2023.
VitaDAO has used this funding to launch new ventures, including Matrix Biosciences, which debuted in October. Another BioDAO, HairDAO, gained recognition as the first decentralized organization to file a scientific patent in December.
As BIO Protocol expands, it aims to address some of the most pressing challenges in biotech. Its next wave of projects will include efforts focused on finding treatments for Long COVID, researching rare diseases, and developing quantum microscopes to observe quantum biological phenomena.
The post <a href="https://thecoinrise.com/binance-labs-ventures-into-decentralized-science-with-investment-in-bio-protocol/" rel="noopener noreferrer nofollow">Binance Labs Ventures into Decentralized Science with Investment in BIO Protocol</a> appeared first on <a href="https://thecoinrise.com/" rel="noopener noreferrer nofollow">TheCoinrise.com</a>.

Binance Labs Ventures into Decentralized Science with Investment in BIO Protocol

Table of Contents

TheCoinrise Media

Other articles published on Nov 9, 2024

What Is Layer 2 in Blockchain?

Ethereum Price Climb: Pushing For New $6,000 ATH To Set This $0.0171 Al Altcoin On Path To 30000%...

Historic Milestone for BlackRock’s Bitcoin Spot ETF – Never Seen Before

Bitcoin Fog Founder Sentenced to 12.5 Years for Laundering $400 Million in Cryptocurrency

This Trader Updates His XRP Price Prediction for When Bitcoin Hits $100K

Vitalik Buterin Envisions a Wider Scope for Prediction Markets

Join our free newsletter for daily crypto updates!